l. INTRODUCTION

l. My name is Murray Wilson and I reside in the City of Ottawa, Ontario.

2. I confirm that I have no relationship to Eli Lilly and Company or any of its affiliates.

3. I worked for the Canadian Patent Office for o ver 3 5 years as a patent examiner and in various other capacities such as the acting Chair of the Patent Appeal Board. Based upon that experience, I believe that 1 am qualified to provide the factual information and opinions set out below.

4. During my 35 year career with the Canadian Patent Office I examined and reviewed thousands of patent applications, including pharmaceutical patents. I have extensive experience and in-depth knowledge about the Canadian Patent Office practice relating to the examination and granting of patents during the time period the Strattera and Zyprexa patent applications were examined and the patents granted (patent 2,209,735 and patent 2,041,113, respectively ).

5. After graduating from Carleton University in 1971 with a Bachelor ofMechanical Engineering Degree, I started working in the Canadian Patent Office in 1971 as a patent examiner in the Mechanical Division, examining patent applications in the material handling arts.

6. In 1981, I became a senior patent examiner with responsibilities for examining patent applications that were filed in French.

7. In 1982, I was appointed Assistant to the Commissioner of Patents/Registrar of Trade-marks.

8. In 1987, I became a project officer in the Policy and Program Planning Branch of the Canadian Intellectual Property Office. This position had various duties including responsibility for the formal training of all new patent examiners.